Latest news with #BritishAmericanTobacco
Yahoo
a day ago
- Business
- Yahoo
British American Tobacco (Malaysia) Berhad First Quarter 2025 Earnings: EPS: RM0.082 (vs RM0.10 in 1Q 2024)
Revenue: RM322.0m (down 22% from 1Q 2024). Net income: RM23.3m (down 22% from 1Q 2024). Profit margin: 7.2% (down from 7.3% in 1Q 2024). The decrease in margin was driven by lower revenue. EPS: RM0.082 (down from RM0.10 in 1Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Tobacco industry in Asia. Performance of the market in Malaysia. The company's shares are down 6.7% from a week ago. Don't forget that there may still be risks. For instance, we've identified 3 warning signs for British American Tobacco (Malaysia) Berhad that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Mail & Guardian
3 days ago
- Business
- Mail & Guardian
Big Tobacco's profit addiction needs a quit plan
New legislation seeks to stop tobacco companies from luring non-smoking teens into becoming addicted to their deadly products. Every year on 31 May, the World Health Organisation hosts Because tobacco Leveraging loopholes to lure youth Until the early 2000s, South African media was saturated with tobacco ads in magazines, on billboards and radio, and in cinemas. Many will recall Peter Stuyvesant's iconic Today, the industry The tobacco industry claims these set-ups only serve to allow them to vie for market share among existing adult smokers but evidence shows these displays also lure young people. A The Tobacco Products and Electronic Delivery Systems Bill, which is being debated in parliament, aims to ban point-of-sale advertising, closing this loophole in the regulatory framework. Global evidence shows that point-of-sale display bans reduce youth smoking Predictably, Big Tobacco is Vaping's surge among youth: Big tobacco's unregulated playbook As a global wave of tobacco-control legislation and excise-tax increases has stifled the industry's ability to expand tobacco sales, companies have pivoted to novel products like e-cigarettes to secure their future revenues. Since 2010, giants like British American Tobacco, Philip Morris International, Japan Tobacco International and Imperial Brands have . In South Africa, Vuse — made by British American Tobacco, producer of the nation's top-selling Peter Stuyvesant cigarettes — stands out with pop-up stalls and concept stores in shopping malls across the country, signalling Big Tobacco's bold entry into vaping. E-cigarettes commonly deliver nicotine, a highly addictive and harmful In South Africa, e-cigarettes are currently unregulated, enabling Big Tobacco and independent vape companies to populate shopping malls with attractive kiosks and flood youth-heavy platforms like TikTok and Instagram with influencer-driven ads and sponsored content. In the current regulatory vacuum, vape marketing has thrived unchecked, The regulatory free-for-all in South Africa has fuelled alarming vaping trends among South African teens. A Among those who use e-cigarettes, 88% puff on vapes that contain nicotine and 47% vape within an hour of waking — a clear marker of addiction. The study estimates 60% of teen vapers are addicted to their vapes, reflecting an extent of use and dependence on nicotine that researchers have never encountered with traditional cigarettes in the past. The Tobacco Products and Electronic Delivery Systems Control Bill aims to regulate e-cigarettes and other novel products like traditional tobacco by, among other things, banning direct advertising, including at the point of sale. Big Tobacco and their front groups claim these products aid smoking cessation among adults wishing to quit tobacco and that advertising bans harm public health by limiting awareness of 'safer' alternatives. Yet the World Health Organisation indicates that On World No Tobacco Day 2025, the urgent need to protect South Africa's young people from exploitative marketing tactics takes centre stage. The Tobacco Products and Electronic Delivery Systems Control Bill rises to this challenge, aiming to regulate vaping, and close loopholes that enable youth-targeted marketing of more traditional tobacco products. The Bill is more than regulation: it demands that Big Tobacco and its affiliates end their predatory marketing aimed at young people and protects South Africa's youth from deceptive tactics which drive lifelong addiction and Sam Filby is a research officer at the Research Unit on the Economics of Excisable Products (REEP) at the University of Cape Town and Corné van Walbeek is a professor in economics at UCT and the director of REEP.
Yahoo
3 days ago
- Business
- Yahoo
Better High-Yield Dividend Stock: Altria or British American Tobacco?
Altria and British American Tobacco have nearly identical dividend yields, growth, and valuations today. Smoke-free nicotine is the industry's future. This is where differences begin to show. It's too soon to panic, but one company is currently in a much better spot for the long term. 10 stocks we like better than British American Tobacco › Sin stocks, such as tobacco companies, aren't for everyone, but they make excellent dividend stocks due to their entrenched and resilient business models and huge profit margins, which allow them to send most of their profits to shareholders. Altria Group (NYSE: MO) and British American Tobacco (NYSE: BTI) are industry leaders with many similarities, including outsized dividends that yield around 7% at their current share prices. But which company would be a better fit in your portfolio? The tobacco industry is evolving, and one company is adapting better. Here is what you need to know. Altria and British American Tobacco sell many of the leading brands of cigarettes and other tobacco products. Altria operates primarily in the U.S., where it sells Marlboro cigarettes. British American Tobacco sells globally, where it competes mainly with Philip Morris International in non-U.S. markets. Investors looking at the financials will quickly notice that these two stocks are strikingly similar. Altria and British American Tobacco have nearly identical dividend yields, anticipated long-term earnings growth, and trade at almost the same valuation. Essentially, both companies are slow-growing, high-yield dividend stocks. You can also count on both companies to continue paying and raising their dividends. Both companies generate enough free cash flow to cover their dividends, and they have multibillion-dollar stakes in other companies that they can liquidate to raise cash. Altria owns a stake in Anheuser-Busch InBev, worth approximately $11 billion at the company's current price. British American Tobacco owns a roughly 25% stake in ITC Limited, an Indian conglomerate worth approximately $16 billion today. Despite the slow demise of traditional cigarettes, tobacco companies have become excellent financial survivalists. Modern society is aware of the health dangers of smoking, which is why cigarette use has been in decline for years. Tobacco companies know this and have spent the past decade rushing to develop and launch smokeless nicotine products that aren't healthy by any means but don't produce the harmful smoke cigarettes do. The big three product categories are electronic cigarettes/vapes, oral nicotine pouches, and heat-not-burn tobacco devices. The tobacco industry is becoming the nicotine industry, and market share is up for grabs as consumers transition from cigarettes to smokeless products. Both companies, directly or through joint ventures, have established offerings in all three smokeless categories. British American Tobacco has thrived with its electronic vape brand, Vuse, with an estimated 40% market share in its core markets. Sales of new product categories represented 13.2% of total revenue in 2024. Altria is much further behind. In 2018, the company invested $12.8 billion in a fast-growing electronic vape company, but the investment was a disaster that set the company back. Altria has worked on alternative plans since then, but sales of new product categories totaled just $300 million in 2024, only 1.2% of total revenue. While both companies should continue to squeeze value out of their cigarette businesses, Altria's long-term growth is currently on shakier ground. Philip Morris International is rolling out its leading heat-not-burn brand, IQOS, in the United States. IQOS offers a similar experience to cigarettes and has successfully converted smokers in other countries. If IQOS thrives and Marlboro's cigarette declines accelerate, it could further pressure Altria. Meanwhile, the U.S. government has begun cracking down on illegal vape products that have flooded the market. It's a win for Altria and British American Tobacco, but the latter should benefit more since Vuse already enjoys a whopping 50% share of the U.S. vaping market. Altria doesn't seem poised to enjoy the same market leadership with these next-generation nicotine products that it has for generations with Marlboro cigarettes. Unless that changes, Altria's business may grow weaker over time as cigarette volumes erode. Change is happening slowly, so Altria can still be an excellent short-term dividend stock. However, British American Tobacco is the superior high-yield stock to buy and hold. Before you buy stock in British American Tobacco, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and British American Tobacco wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,761!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $826,263!* Now, it's worth noting Stock Advisor's total average return is 978% — a market-crushing outperformance compared to 170% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Justin Pope has no position in any of the stocks mentioned. The Motley Fool recommends British American Tobacco P.l.c. and Philip Morris International and recommends the following options: long January 2026 $40 calls on British American Tobacco and short January 2026 $40 puts on British American Tobacco. The Motley Fool has a disclosure policy. Better High-Yield Dividend Stock: Altria or British American Tobacco? was originally published by The Motley Fool
Yahoo
3 days ago
- Business
- Yahoo
Better High-Yield Dividend Stock: Altria or British American Tobacco?
Altria and British American Tobacco have nearly identical dividend yields, growth, and valuations today. Smoke-free nicotine is the industry's future. This is where differences begin to show. It's too soon to panic, but one company is currently in a much better spot for the long term. 10 stocks we like better than British American Tobacco › Sin stocks, such as tobacco companies, aren't for everyone, but they make excellent dividend stocks due to their entrenched and resilient business models and huge profit margins, which allow them to send most of their profits to shareholders. Altria Group (NYSE: MO) and British American Tobacco (NYSE: BTI) are industry leaders with many similarities, including outsized dividends that yield around 7% at their current share prices. But which company would be a better fit in your portfolio? The tobacco industry is evolving, and one company is adapting better. Here is what you need to know. Altria and British American Tobacco sell many of the leading brands of cigarettes and other tobacco products. Altria operates primarily in the U.S., where it sells Marlboro cigarettes. British American Tobacco sells globally, where it competes mainly with Philip Morris International in non-U.S. markets. Investors looking at the financials will quickly notice that these two stocks are strikingly similar. Altria and British American Tobacco have nearly identical dividend yields, anticipated long-term earnings growth, and trade at almost the same valuation. Essentially, both companies are slow-growing, high-yield dividend stocks. You can also count on both companies to continue paying and raising their dividends. Both companies generate enough free cash flow to cover their dividends, and they have multibillion-dollar stakes in other companies that they can liquidate to raise cash. Altria owns a stake in Anheuser-Busch InBev, worth approximately $11 billion at the company's current price. British American Tobacco owns a roughly 25% stake in ITC Limited, an Indian conglomerate worth approximately $16 billion today. Despite the slow demise of traditional cigarettes, tobacco companies have become excellent financial survivalists. Modern society is aware of the health dangers of smoking, which is why cigarette use has been in decline for years. Tobacco companies know this and have spent the past decade rushing to develop and launch smokeless nicotine products that aren't healthy by any means but don't produce the harmful smoke cigarettes do. The big three product categories are electronic cigarettes/vapes, oral nicotine pouches, and heat-not-burn tobacco devices. The tobacco industry is becoming the nicotine industry, and market share is up for grabs as consumers transition from cigarettes to smokeless products. Both companies, directly or through joint ventures, have established offerings in all three smokeless categories. British American Tobacco has thrived with its electronic vape brand, Vuse, with an estimated 40% market share in its core markets. Sales of new product categories represented 13.2% of total revenue in 2024. Altria is much further behind. In 2018, the company invested $12.8 billion in a fast-growing electronic vape company, but the investment was a disaster that set the company back. Altria has worked on alternative plans since then, but sales of new product categories totaled just $300 million in 2024, only 1.2% of total revenue. While both companies should continue to squeeze value out of their cigarette businesses, Altria's long-term growth is currently on shakier ground. Philip Morris International is rolling out its leading heat-not-burn brand, IQOS, in the United States. IQOS offers a similar experience to cigarettes and has successfully converted smokers in other countries. If IQOS thrives and Marlboro's cigarette declines accelerate, it could further pressure Altria. Meanwhile, the U.S. government has begun cracking down on illegal vape products that have flooded the market. It's a win for Altria and British American Tobacco, but the latter should benefit more since Vuse already enjoys a whopping 50% share of the U.S. vaping market. Altria doesn't seem poised to enjoy the same market leadership with these next-generation nicotine products that it has for generations with Marlboro cigarettes. Unless that changes, Altria's business may grow weaker over time as cigarette volumes erode. Change is happening slowly, so Altria can still be an excellent short-term dividend stock. However, British American Tobacco is the superior high-yield stock to buy and hold. Before you buy stock in British American Tobacco, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and British American Tobacco wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,761!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $826,263!* Now, it's worth noting Stock Advisor's total average return is 978% — a market-crushing outperformance compared to 170% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Justin Pope has no position in any of the stocks mentioned. The Motley Fool recommends British American Tobacco P.l.c. and Philip Morris International and recommends the following options: long January 2026 $40 calls on British American Tobacco and short January 2026 $40 puts on British American Tobacco. The Motley Fool has a disclosure policy. Better High-Yield Dividend Stock: Altria or British American Tobacco? was originally published by The Motley Fool
Time of India
4 days ago
- Business
- Time of India
British American Tobacco sells $1.5 billion stake in India's ITC via block deal
HighlightsBritish American Tobacco sold a $1.5 billion stake in Indian consumer goods company ITC at 413 Indian rupees per share, exceeding its initial plan to sell up to 290 million shares. The sale of 313 million shares in ITC represented 2.5% of the company, with ITC's stock dropping nearly 3% to 421.70 rupees following the announcement. British American Tobacco plans to increase its 2025 share buyback program by 200 million pounds as a result of the deal, while remaining ITC's largest shareholder. By Scott Murdoch - British American Tobacco has sold a $1.5 billion stake in Indian consumer goods company ITC at 413 Indian rupees per share, according to a term sheet seen by Reuters. The company sold 313 million shares in ITC, representing 2.5% of ITC, according to the term sheet. This final amount exceeded its initial plan to sell up to 290 million shares in the deal, valued at approximately $1.4 billion. The final sale price represented a 4.8% discount to ITC's closing price of 433.90 rupees on Tuesday. Shares of ITC dropped nearly 3% to 421.70 rupees on Wednesday. The stock was the top loser on both Nifty 50 and the FMCG index. BAT will remain ITC's largest shareholder after the deal, according to LSEG data. Goldman Sachs and Citigroup led the deal, the term sheet showed. The deal is the second major block trade in India this week after IndiGo co-founder Rakesh Gangwal sold a 5.7% stake in the low-cost carrier worth $1.36 billion. BAT said it would increase its 2025 1.1 billion pounds ($1.49 billion) share buyback programme by 200 million pounds as a result of the deal, which is not expected to have any other impact on its annual outlook. The London-listed cigarette maker had last year sold 436.9 million shares, or roughly 3.5% of ITC's outstanding shares, for about $2 billion in what was India's third-largest block deal ever. The British firm in February forecast 1% growth in its annual revenue, citing tax headwinds in key markets such as Bangladesh and Australia.
